The podcasts will dive into latest research, solutions for addressing practice management issues, and much more. This is a great learning opportunity not only for trainees but all BSPGHAN members!
https://podcasts.apple.com/at/podcast/espghan-podcast/id1614905161?i=1000556022957
Tune in every other week!
Currently there is no clinical standard for investigation / management of congenital sucrase-isomaltase deficiency (CSID). Dr Sam Huthart, Dr Zamvar, Dr Sims and Dr Kontaki from Leeds Teaching Hospitals Trust have put together a google form with the aim of surveying national prevalence, investigation and management of CSID to obtain epidemiological data and establish best-practice.
To all paediatric gastroenterologists nationwide please help the Leeds team to achieve these outcomes by completing the following survey: Surveying National Prevalence, Investigation and Management of Congenital Sucrase-Isomaltase Deficiency (CSID) – Google Forms
This page is restricted to BSPGHAN members.
Please login.
Dear members
I would like to personally thank the PGHAN Audit Steering Group, co chaired by John Fell and Ed Gaynor, Calvin Down from the RCPCH and all colleagues across the UK who have put time and effort into collecting and submitting information for the audit. This work continued to completion during the incredibly challenging circumstances of the COVID-19 pandemic.
This report, published jointly by The British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) and the RCPCH, highlights the main findings and recommendations identified through an audit of the provision of paediatric gastroenterology, hepatology and nutrition services for infants, children and young people with a wide range of conditions across the UK. Its recommendations offer healthcare professionals and providers expert guidance to drive improvement where needed.
The News page is here :https://www.rcpch.ac.uk/news-events/news/paediatricians-launch-landmark-report-gastrointestinal-liver-nutritional-disorders
Download your copy of The PGHAN/Audit report
Download Summaryof the PGHAN/ Audit report
Also see tweets https://twitter.com/RCPCHtweets/status/1471489611054551041
Sue Protheroe
BSPGHAN President 2019 - 2022
Dear members
Please see updated Guidance from the JCVI
in addition to previous advice
At this time,
This currently includes children with severe neuro-disabilities, Down’s Syndrome, underlying conditions resulting in immunosuppression, profound and multiple learning disabilities (PMLD), severe learning disabilities or who are on the learning disability register. Details regarding additional person-groups with underlying health conditions to be offered vaccination will be provided as updates in the Green Book.
Children and young people aged 12 years and over who are household contacts of persons (adults or children) who are immunosuppressed should be offered 2 doses of Pfizer-BNT162b2 vaccine.
The rollout of Covid vaccination in England will be led through primary care. The letter notes: “We recognise that not all eligible 12-15 year olds may be identified through the GP record. Therefore, any approach by parents of children at increased risk should be considered and clinical judgement used around eligibility in line with JCVI advice. In addition, trusts may refer 12-15 year olds for a COVID-19 vaccination if they consider them to be eligible”
Letter to primary care -
https://www.england.nhs.uk/coronavirus/publication/covid-19-vaccination-programme-actions-for-all-practices-to-support-vaccinating-eligible-12-15-year-olds/
FAQs on Vaccination delivery operations
https://www.england.nhs.uk/coronavirus/publication/vaccinating-children-and-young-people-faq
Best wishes
Sue
Dr S Protheroe
BSPGHAN President
Contact Us l Privacy Policy l Members Login
© 2021 British Society of Paediatric Gastroenterology, Hepatology and Nutrition l Charity Number 299294 l VAT registration number 323665308